tiprankstipranks
Trending News
More News >
Inventiva’s Strategic Advancements and Financial Positioning Drive Buy Rating
PremiumRatingsInventiva’s Strategic Advancements and Financial Positioning Drive Buy Rating
2M ago
Inventiva’s Promising Future: Buy Rating Backed by Phase III Milestone and Financial Stability
Premium
Ratings
Inventiva’s Promising Future: Buy Rating Backed by Phase III Milestone and Financial Stability
2M ago
Inventiva SA Earnings Call: Positive Outlook Amid Challenges
Premium
Company Announcements
Inventiva SA Earnings Call: Positive Outlook Amid Challenges
2M ago
Optimistic Buy Rating for Inventiva Driven by Lanifibranor’s Promising Phase 3 Prospects and Safety Profile
PremiumRatingsOptimistic Buy Rating for Inventiva Driven by Lanifibranor’s Promising Phase 3 Prospects and Safety Profile
3M ago
Inventiva &  Japan’s Hepalys start lanifibranor clinical development program
Premium
The Fly
Inventiva & Japan’s Hepalys start lanifibranor clinical development program
3M ago
Buy Rating for Inventiva: Strategic Focus on Lanifibranor and Strong Financial Outlook
Premium
Ratings
Buy Rating for Inventiva: Strategic Focus on Lanifibranor and Strong Financial Outlook
3M ago
Inventiva announces DMC recommendation to continue NATiV3 trial as is
PremiumThe FlyInventiva announces DMC recommendation to continue NATiV3 trial as is
7M ago
Inventiva price target lowered to $13 from $14 at H.C. Wainwright
Premium
The Fly
Inventiva price target lowered to $13 from $14 at H.C. Wainwright
7M ago
Inventiva announces financing of up to EUR 348M to advance NATiV3 Phase 3 study
Premium
The Fly
Inventiva announces financing of up to EUR 348M to advance NATiV3 Phase 3 study
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100